Biopharmaceutical Company Announces Master Plan With Medical Technology Provider
Silo Pharma and Resyca BV Enter Device and CMC Development Master Plan.
Disclaimer: This article provides information based on an announcement by Silo Pharma Inc. and Resyca BV. The details contained herein are intended for informational purposes only and should not be construed as professional or investment advice.
Real-time information is available daily at https://stockregion.net